Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SIRT7 and p53 interaction in embryonic development and tumorigenesis.
Vazquez BN, Fernández-Duran I, Hernandez Y, Tarighi S, Thackray JK, Espinosa-Alcantud M, Kumari P, Ianni A, Cesaire L, Braun T, Esteller M, Tischfield J, Vaquero A, Serrano L. Vazquez BN, et al. Among authors: cesaire l. Front Cell Dev Biol. 2024 Jan 3;11:1281730. doi: 10.3389/fcell.2023.1281730. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38234684 Free PMC article.
18F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital.
Le Goubey JB, Lasnon C, Nakouri I, Césaire L, de Pontville M, Nganoa C, Kottler D, Aide N. Le Goubey JB, et al. Among authors: cesaire l. Diagnostics (Basel). 2021 Jul 1;11(7):1198. doi: 10.3390/diagnostics11071198. Diagnostics (Basel). 2021. PMID: 34359281 Free PMC article.
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.
Hober C, Fredeau L, Pham-Ledard A, Boubaya M, Herms F, Celerier P, Aubin F, Beneton N, Dinulescu M, Jannic A, Meyer N, Duval-Modeste AB, Cesaire L, Neidhardt ÈM, Archier É, Dréno B, Lesage C, Berthin C, Kramkimel N, Grange F, de Quatrebarbes J, Stoebner PE, Poulalhon N, Arnault JP, Abed S, Bonniaud B, Darras S, Heidelberger V, Devaux S, Moncourier M, Misery L, Mansard S, Etienne M, Brunet-Possenti F, Jacobzone C, Lesbazeilles R, Skowron F, Sanchez J, Catala S, Samimi M, Tazi Y, Spaeth D, Gaudy-Marqueste C, Collard O, Triller R, Pracht M, Dumas M, Peuvrel L, Combe P, Lauche O, Guillet P, Reguerre Y, Kupfer-Bessaguet I, Solub D, Schoeffler A, Bedane C, Quéreux G, Dalac S, Mortier L, Maubec È. Hober C, et al. Among authors: cesaire l. Cancers (Basel). 2021 Jul 15;13(14):3547. doi: 10.3390/cancers13143547. Cancers (Basel). 2021. PMID: 34298764 Free PMC article.
Assessing immune organs on 18F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patients.
Prigent K, Lasnon C, Ezine E, Janson M, Coudrais N, Joly E, Césaire L, Stefan A, Depontville M, Aide N. Prigent K, et al. Among authors: cesaire l. Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2573-2585. doi: 10.1007/s00259-020-05103-3. Epub 2021 Jan 12. Eur J Nucl Med Mol Imaging. 2021. PMID: 33432374